Corpus Intelligence IC Memo — MCHS OAKRIDGE 2026-04-26 09:08 UTC
IC Memo — MCHS OAKRIDGE
Investment Committee Memorandum | WI | 18 beds | Grade C | EBITDA uplift $2.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MCHS OAKRIDGE

CCN 521302 | nan, WI | 18 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MCHS OAKRIDGE is a 18-bed rural/critical access in nan, WI with $26.9M in net patient revenue and a -17.6% operating margin. The hospital serves a payer mix of 51.5% Medicare, 0.7% Medicaid, and 47.8% commercial.

Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -17.6% to -10.2% (+736bps).

Net Revenue HCRIS$26.9M
Current EBITDA COMPUTED$-4.7M
Operating Margin COMPUTED-17.6%
Occupancy HCRIS59.1%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS56.9%
Distress Probability ML48.5%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
73
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -17.6% places it below the state median. Among 73 size-comparable peers (9-36 beds), the median margin is 3.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (9-36), prioritizing same-state peers. 73 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MCHS OAKRIDGE (Target)WI18$26.9M-17.6%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
MEMORIAL MEDICAL CENTER INC.WI25$138.4M8.1%
MARSHFIELD MEDICAL CENTER-MINOWI19$129.6M-12.4%
MCHS-RED CEDARWI25$123.4M16.8%
MEMORIAL HOSPITAL OF BURLINGTOWI33$118.8M15.3%
OAK LEAF SURGICAL HOSPITAL LLCWI13$109.8M34.1%
SAUK PRAIRIE MEMORIAL HOSPITALWI36$109.1M-0.1%
ST CROIX REGIONAL MEDICAL CENTWI25$108.4M-31.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$565K+210bp18mo
Cost to Collect4.5%2.5%$538K+200bp12mo
Denial Rate Reduction12.0%6.5%$533K+198bp12mo
A/R Days Reduction5200.0%3800.0%$328K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$565K
Cost to Collect
$538K
Denial Rate Reduction
$533K
A/R Days Reduction
$328K
Clean Claim Rate
$17K
Total EBITDA Uplift$2.0M
Current EBITDA$-4.7M
+ RCM Uplift+$2.0M
Pro Forma EBITDA$-2.7M
Current Margin-17.6%
Pro Forma Margin-10.2%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.3M$-11.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.3M$-14.9M0.00x-100.0%
Bull Case9.0x11.0x$-6.5M$-10.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.5M$-13.6M0.00x-100.0%
Bear Case11.0x10.0x$-8.0M$-18.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-8.0M$-23.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 73 hospitals with 9-36 beds
  • Same-state prioritization (n=74)
  • Comp margins: P25=-3.0% / P50=3.5% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.